Botulinum toxin in the treatment of post-traumatic headache – case study

Bouillon, 1999, The incidence and outcome of severe brain trauma – design and first results of an epidemiological study in an urban area, Restor Neurol Neurosci, 14, 85 Pfaffenrath, 2008, Differenzialdiagnostische Tipps für die Praxis. So packen Sie den Kopfschmerz an der Wurzel, MMW Fortschr Med, 150, 46, 10.1007/BF03365587 Keidel, 1997, Der posttraumatische Kopfschmerz, Nervenarzt, 68, 769, 10.1007/s001150050193 Keidel, 2001, Therapie des posttraumatischen Kopfschmerzes nach Schädel-Hirn-Trauma und HWS-Distorsion. Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft, Manuelle Medizin, 39, 259, 10.1007/s003370170023 Keidel, 2007, Posttraumatischer Kopfschmerz, Nervenheilkunde, 26, 156, 10.1055/s-0038-1626843 Wacker, 2000, Epidemiologie und Komorbidität von Depressionen. Therapeutische Umschau, Rev Ther, 57, 53 Jost, 2003, Botulinumtoxin beim Kopfschmerz vom Spannungstyp, Fortschr Neurol Psychiatr, 71, 296, 10.1055/s-2003-39592 Dowson, 2008, Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting, Drugs R D, 9, 147, 10.2165/00126839-200809030-00002 Hamdy, 2009, Botulinum toxin: could it be an effective treatment for chronic tension-type headache?, J Headache Pain, 10, 27, 10.1007/s10194-008-0082-2 Evers, 2007, Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache, Neuropsychiatr Dis Treat, 3, 761, 10.2147/NDT.S1665 Chan, 2009, Botox treatment for migraine and chronic daily headache in adolescents, Neurosci Nurs, 41, 235, 10.1097/JNN.0b013e3181aaa98f Magalhães, 2010, Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine, Clin Neurol Neurosurg, 112, 463, 10.1016/j.clineuro.2010.02.004 Shuhendler, 2009, Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials, Pharmacotherapy, 29, 784, 10.1592/phco.29.7.784 De Ru, 2009, Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache, J Laryngol Otol, 123, 412, 10.1017/S0022215108003198 Mathew, 2005, Botulinum toxin type A (BOTOX®) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial, Headache, 45, 293, 10.1111/j.1526-4610.2005.05066.x Freitag, 2008, Botulinum toxin type A in the treatment of chronic migraine without medication overuse, Headache, 48, 201 Silberstein, 2000, Botulinum toxin type A as a migraine preventive treatment, Headache, 40, 445, 10.1046/j.1526-4610.2000.00066.x Silberstein, 2005, Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial, Mayo Clin Proc, 80, 1126, 10.4065/80.9.1126 Aurora, 2007, Botulinum toxin type A prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study, Headache, 47, 486 Silberstein, 2006, Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study, Cephalalgia, 26, 790, 10.1111/j.1468-2982.2006.01114.x Dodick, 2010, Onabotulinumtoxin A for treatment of chronic migraine: pooled results from the double-blind, randomized placebo-controlled phases of the PREEMPT clinical program, Headache, 50, 921, 10.1111/j.1526-4610.2010.01678.x Aurora, 2010, Onabotulinumtoxin A for treatment of chronic migraine: results from the double-blind, randomized placebo-controlled phase of the PREEMPT 1 trial, Cephalalgia, 30, 793, 10.1177/0333102410364676 Diener, 2010, Onabotulinumtoxin A for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial, Cephalalgia, 30, 804, 10.1177/0333102410364677 Saper, 2007, A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine, Pain Med, 8, 478, 10.1111/j.1526-4637.2006.00168.x Elkind, 2006, A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis, J Pain, 7, 688, 10.1016/j.jpain.2006.03.002 Relja, 2007, A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches, Cephalalgia, 27, 492, 10.1111/j.1468-2982.2007.01315.x Mitchell, 2008, Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization, J Manag Care Pharm, 14, 442, 10.18553/jmcp.2008.14.5.442